Accessibility Statement
Apostle Diagnostics Labs LLC · San Ramon, CA
Our commitment
We are committed to making the Apostle Diagnostics website accessible to people of all abilities. Our goal is conformance with WCAG 2.2 Level AA, the widely recognized standard for web accessibility.
What we have done
- Semantic page structure with landmarks, headings in order and a “Skip to main content” link.
- Text and interface colors chosen to meet WCAG contrast requirements.
- Every feature can be used with a keyboard, with a clearly visible focus indicator.
- Descriptive alternative text for meaningful images.
- Forms with visible labels, clear instructions and error messages that explain how to fix problems.
- Respect for your device’s “reduce motion” setting — page transitions and animations are turned off.
- Pages that work when zoomed to 200% and on small screens.
Compatibility
The site is designed to work with current versions of Chrome, Edge, Safari and Firefox, and with screen readers including NVDA, JAWS and VoiceOver.
Known limitations
To protect our inbox from spam, showing our email address and sending the contact form require a short automated human check that runs in your browser and needs JavaScript. It does not ask you to solve visual puzzles. If you cannot use it for any reason, please call us at (925) 392-1134 — we are happy to help by phone.
Feedback and accommodation requests
If you have difficulty using any part of this website, or need information in another format, please let us know. Call (925) 392-1134, use our contact form, or write to Apostle Diagnostics Labs LLC, 2603 Camino Ramon, Suite 200, San Ramon, CA 94583. Please tell us the page and the problem, and how we can reach you. We aim to respond within five business days.
Nondiscrimination
Apostle Diagnostics Labs LLC does not discriminate on the basis of race, color, national origin, age, disability or sex. Language assistance and auxiliary aids are available on request by calling (925) 392-1134.
Review date
This statement was last reviewed on November 1, 2026.